Literature DB >> 17054103

Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives.

Alex Dmitrienko1, Brian L Wiens, Ajit C Tamhane, Xin Wang.   

Abstract

This paper discusses a new class of multiple testing procedures, tree-structured gatekeeping procedures, with clinical trial applications. These procedures arise in clinical trials with hierarchically ordered multiple objectives, for example, in the context of multiple dose-control tests with logical restrictions or analysis of multiple endpoints. The proposed approach is based on the principle of closed testing and generalizes the serial and parallel gatekeeping approaches developed by Westfall and Krishen (J. Statist. Planning Infer. 2001; 99:25-41) and Dmitrienko et al. (Statist. Med. 2003; 22:2387-2400). The proposed testing methodology is illustrated using a clinical trial with multiple endpoints (primary, secondary and tertiary) and multiple objectives (superiority and non-inferiority testing) as well as a dose-finding trial with multiple endpoints. Copyright 2006 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2007        PMID: 17054103     DOI: 10.1002/sim.2716

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  14 in total

1.  Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk.

Authors:  Yongyue Wei; Zhaoxi Wang; Li Su; Feng Chen; Paula Tejera; Ednan K Bajwa; Mark M Wurfel; Xihong Lin; David C Christiani
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

2.  A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials.

Authors:  Xiaobo Zhong; Bin Cheng; Min Qian; Ying Kuen Cheung
Journal:  Contemp Clin Trials       Date:  2019-08-27       Impact factor: 2.226

3.  On Consistency of Self- and Proxy-reported Regular Smoking Initiation Age.

Authors:  Julia N Soulakova; Brianna C Bright; Lisa J Crockett
Journal:  J Subst Abus Alcohol       Date:  2013-12-16

4.  Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Ellen L Poleshuck; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

5.  A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.

Authors:  Yongyue Wei; Paula Tejera; Zhaoxi Wang; Ruyang Zhang; Feng Chen; Li Su; Xihong Lin; Ednan K Bajwa; B Taylor Thompson; David C Christiani
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

6.  Closed Testing in Pharmaceutical Research: Historical and Recent Developments.

Authors:  Kevin S S Henning; Peter H Westfall
Journal:  Stat Biopharm Res       Date:  2015       Impact factor: 1.452

7.  Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: An ACTTION Systematic Review.

Authors:  Jennifer S Gewandter; Jenna Chaudari; Katarzyna B Iwan; Rachel Kitt; Sawsan As-Sanie; Gloria Bachmann; Quentin Clemens; H Henry Lai; Frank Tu; G Nicholas Verne; Katy Vincent; Ursula Wesselmann; QiQi Zhou; Dennis C Turk; Robert H Dworkin; Shannon M Smith
Journal:  J Pain       Date:  2018-02-02       Impact factor: 5.820

8.  The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol.

Authors:  Signe Stelling Risom; Ann-Dorth Olsen Zwisler; Trine Bernholdt Rasmussen; Kirstine Lærum Sibilitz; Jesper Hastrup Svendsen; Christian Gluud; Jane Lindschou Hansen; Per Winkel; Lau Caspar Thygesen; Merja Perhonen; Jim Hansen; Sandra B Dunbar; Selina Kikkenborg Berg
Journal:  BMJ Open       Date:  2013-02-20       Impact factor: 2.692

9.  Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

Authors:  R S Desikan; A J Schork; Y Wang; A Witoelar; M Sharma; L K McEvoy; D Holland; J B Brewer; C-H Chen; W K Thompson; D Harold; J Williams; M J Owen; M C O'Donovan; M A Pericak-Vance; R Mayeux; J L Haines; L A Farrer; G D Schellenberg; P Heutink; A B Singleton; A Brice; N W Wood; J Hardy; M Martinez; S H Choi; A DeStefano; M A Ikram; J C Bis; A Smith; A L Fitzpatrick; L Launer; C van Duijn; S Seshadri; I D Ulstein; D Aarsland; T Fladby; S Djurovic; B T Hyman; J Snaedal; H Stefansson; K Stefansson; T Gasser; O A Andreassen; A M Dale
Journal:  Mol Psychiatry       Date:  2015-02-17       Impact factor: 15.992

10.  A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis--the CopenHeartIE trial protocol.

Authors:  Trine Bernholdt Rasmussen; Ann-Dorthe Zwisler; Kirstine Lærum Sibilitz; Signe Stelling Risom; Henning Bundgaard; Christian Gluud; Philip Moons; Per Winkel; Lau Caspar Thygesen; Jane Lindschou Hansen; Tone Merete Norekvål; Selina Kikkenborg Berg
Journal:  BMJ Open       Date:  2012-11-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.